- Grupo Santander downgraded Braskem S.A. (NYSE: BAK) from “Neutral” to “Underperform” due to ongoing financial health and strategic direction concerns.
- Pomerantz LLP is investigating Braskem for potential securities fraud following a significant drop in ADR price after announcing the exploration of financial alternatives.
- Despite recent challenges, Braskem’s stock shows resilience with a slight increase, amidst significant volatility over the past year.
Braskem S.A. (NYSE: BAK) is a leading petrochemical company based in Brazil, specializing in the production of thermoplastic resins and other petrochemical products. The company operates globally, with a significant presence in the Americas, Europe, and Asia, facing competition from major industry players like Dow Chemical and BASF.
On October 15, 2025, Grupo Santander downgraded Braskem’s stock from “Neutral” to “Underperform,” indicating a more bearish outlook. At the time, the stock was priced at $2.54. This downgrade comes amid ongoing concerns about Braskem’s financial health and strategic direction, as highlighted by recent developments.
Pomerantz LLP is investigating Braskem for potential securities fraud or other unlawful practices. This investigation follows Braskem’s announcement on September 26, 2025, about engaging advisors to explore financial alternatives. This news led to a 14.71% drop in Braskem’s ADR price, closing at $2.61, reflecting investor concerns.
Despite the downgrade and investigation, Braskem’s stock has shown some resilience. It is currently priced at $2.54, a 1.6% increase from the previous day. The stock has fluctuated between $2.43 and $2.55 today, with a market cap of approximately $1.01 billion. The trading volume on the NYSE is 526,021 shares.
Over the past year, Braskem’s stock has experienced significant volatility, reaching a high of $6.56 and a low of $2.32. This volatility reflects the challenges and uncertainties the company faces in optimizing its capital structure and addressing legal concerns.
